ArticleScience (New York, N.Y.)2021
Age groups that sustain resurging COVID-19 epidemics in the United States.
Article in Science (New York, N.Y.), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 171 papers, 3 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
171 citing papers in PubMed, 3 syntheses or guidelines pooled it, 353 citations in OpenAlex.
- Attitudes of COVID-19 vaccination among college students: A systematic review and meta-analysis of willingness, associated determinants, and reasons for hesitancy.Human vaccines & immunotherapeutics · 2022Pooled it
- Duration of SARS-CoV-2 shedding and infectivity in the working age population: a systematic review and meta-analysis.La Medicina del lavoro · 2022Pooled it
- Measures implemented in the school setting to contain the COVID-19 pandemicThe Cochrane database of systematic reviews · 2022Pooled it
- Trial
- Estimated Health Outcomes and Costs of COVID-19 Prophylaxis With Monoclonal Antibodies Among Unvaccinated Household Contacts in the US.JAMA network open · 2022Trial
- Increased vulnerability to SARS-CoV-2 infection among indigenous people living in the urban area of Manaus.Scientific reports · 2021Trial
- Modeling individual self-protective behavior during epidemics.PLoS computational biology · 2026Article
- Assessing the Impact of Timing and Coverage of United States COVID-19 Vaccination Campaigns: A Multi-Model Approach.medRxiv : the preprint server for health sciences · 2026Article
- Faster than Virus: The Physics of Pandemic Prediction.Infectious disease reports · 2026Article
- Changing socioeconomic inequalities in the incidence and case fatality rates of COVID-19 in Germany, March 2020 through May 2022: an ecological study.BMC public health · 2025Article
- Evolving infectious disease dynamics shape school-based intervention effectiveness.Nature communications · 2025Article
- Examining epidemiologic disparity across SARS-CoV-2 variant-dominant periods in Oklahoma County, Oklahoma (March 12, 2020-February 28, 2022).Journal of public health research · 2025Article
- Article
- Scaling COVID-19 rates with population size in the United States.Journal of the Royal Society, Interface · 2025Article
- Relationships among physical activity, regulatory emotional self-efficacy, psychological detachment, and job burnout among urban workers.Frontiers in public health · 2025Article
- Asymmetric limits on timely interventions from noisy epidemic data.Communications physics · 2025Article
- Health anxiety and physical activity among young and middle-aged employees: the role of self-compassion and coping strategies.Frontiers in psychology · 2025Article
- COVID-19 testing experiences and attitudes among young adults and socially isolated older adults living in public housing, New York City (2022).Frontiers in public health · 2025Article
- Spatio-temporal forecasting of COVID-19 cases in the Netherlands for source and contact tracing.International journal of population data science · 2025Article
- Factors associated with the COVID-19 booster vaccine intentions of young adults in the United States.Human vaccines & immunotherapeutics · 2024Article
111 more citing papers are in PubMed but not listed here.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
28 authors at 7 institutions in 5 countries.
Funding
Abstract
After initial declines, in mid-2020 a resurgence in transmission of novel coronavirus disease (COVID-19) occurred in the United States and Europe. As efforts to control COVID-19 disease are reintensified, understanding the age demographics driving transmission and how these affect the loosening of interventions is crucial. We analyze aggregated, age-specific mobility trends from more than 10 million individuals in the United States and link these mechanistically to age-specific COVID-19 mortality data. We estimate that as of October 2020, individuals aged 20 to 49 are the only age groups sustaining resurgent SARS-CoV-2 transmission with reproduction numbers well above one and that at least 65 of 100 COVID-19 infections originate from individuals aged 20 to 49 in the United States. Targeting interventions-including transmission-blocking vaccines-to adults aged 20 to 49 is an important consideration in halting resurgent epidemics and preventing COVID-19-attributable deaths.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.